Superposition Announces Aptos Mainnet Launch to Scale Novel Web3 Universal Credit Hub
April 04, 2024 09:00 ET
|
Superposition Finance
The Multi-chain Credit Platform Combines Unmatched Risk Management Capabilities With Capital-efficient Growth Potential Powered by Concordia's Modular Risk Layer, Enabling Maximized Returns With...
Aptose Reports Results for the Fourth Quarter and Full Year 2023
March 26, 2024 16:01 ET
|
Aptose Biosciences, Inc.
Aptose Reports Results for the Fourth Quarter and Full Year 2023
Aptose to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update on Tuesday, March 26, 2024
March 18, 2024 16:30 ET
|
Aptose Biosciences, Inc.
Aptose to Report Fourth Quarter and Year End 2023 Financial Results and
Provide Corporate Update on Tuesday, March 26, 2024
Grayscale® Advisors New Investment Opportunity Aims to Capture Staking Rewards
March 05, 2024 11:00 ET
|
Grayscale Investments
STAMFORD, Conn., March 05, 2024 (GLOBE NEWSWIRE) -- Grayscale® Advisors, LLC (“GSA”), an SEC-registered investment adviser, today announced the launch of Grayscale Dynamic Income Fund (“GDIF” or...
MissionSquare Retirement Renews Partnerships with Public Service Organizations in California, Florida, Michigan, and New York to Bolster Retirement Security for Local Government Employees
March 05, 2024 10:00 ET
|
MissionSquare Retirement
Washington, D.C., March 05, 2024 (GLOBE NEWSWIRE) -- MissionSquare Retirement, a staunch advocate for retirement security and financial well-being, is pleased to announce the renewal of partnerships...
Zero Hash bolsters its ecosystem support with addition of Aptos blockchain
March 01, 2024 09:25 ET
|
Zero Hash
CHICAGO, March 01, 2024 (GLOBE NEWSWIRE) -- Zero Hash, the leading crypto and stable coin infrastructure platform, today announced that its customers can access the APT token on the Aptos...
Janssen recibe la opinión positiva del CHMP para CARVYKTI®▼ (ciltacabtagén autoleucel; cilta-cel) para el tratamiento en líneas más tempranas de mieloma múltiple en recaída y refractario
February 28, 2024 14:25 ET
|
Janssen Pharmaceutica NV
Los resultados del estudio de fase 3 CARTITUDE-4, que respaldaron la recomendación del CHMP, demostraron que cilta-cel podría ofrecer un beneficio significativo a los pacientes en líneas de...
Flash News: OKX Wallet now integrated with Merkle Trade
February 11, 2024 06:00 ET
|
OKX
SINGAPORE, Feb. 11, 2024 (GLOBE NEWSWIRE) -- OKX, a leading Web3 technology company, has issued updates for February 11, 2024. OKX Wallet is now integrated with Merkle Trade, the first gamified...
Creta and Republic Form Strategic Partnership to Revolutionize Web3 and Metaverse Gaming
February 07, 2024 12:00 ET
|
Creta
Dubai, UAE, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Republic, international finance technology company, has deployed $2.6+ billion worth of investments into thousands of private ventures. Engaging...
Aptose Announces Closing of $9.7 Million Public Offering and Concurrent $4 Million Private Placement with Hanmi Pharmaceutical, Including Full Exercise of Over-Allotment Option
January 31, 2024 16:01 ET
|
Aptose Biosciences, Inc.
Aptose closes previously announced public offering and private placement